Aurigene Discovery Technologies Is A Clinical Stage Biotechnology Company Based In Bangaloreindiafocused On Oncology Drug Discovery And Developmentfounded In 2001The Company Has Over 20 Years Of Experience And Employs More Than 425 Scientistsaurigene Has Developed 21 Novel Chemical Entitiesncesfor Clinical Developmentwith Several Out Licensed To Global Pharmaceutical Partnersnotable Achievements Include Initiating A Phase 1 Trial For Aur112A Malt1 Inhibitorand Securing Global Rights For Ca 170An Immune Checkpoint Program The Company Specializes In Drug Discoveryincluding Oncology Target Identification And Preclinical Developmentaurigene Collaborates With Global Pharmaceutical And Biotech Companiesoffering Full Time Equivalent And Fee For Service Modelsits Pipeline Features Small Molecule Inhibitors And Immune Oncology Therapiessuch As Aur112 And Ca 170Along With Multiple Out Licensed Programsaurigene Is Dedicated To Improving The Lives Of Cancer Patients Through Innovation And Teamwork Among Its Scientists
United States
